Saint Luke's Cancer Institute - Boise — Boise, Idaho

Public research footprint of Saint Luke's Cancer Institute - Boise, compiled from the ClinicalTrials.gov public registry.

334

Registered studies

249

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Recurrent Malignant Female Reproductive System Neoplasm

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Saint Luke's Cancer Institute - Boise?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.